Article

Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma

2024-02-26

Abstract excerpt

<title>Abstract</title> <p>Background There is growing interest in multiple myeloma (MM) circulating tumor cells (CTCs), but its rareness in peripheral blood (PB) and inconsistency in cutoffs question their clinical utility. Herein, we aimed at defining the optimal CTC cutoff using a highly sensitive approach. Moreover, we analyzed matched bone marrow (BM) and PB samples in order to highlight inconsistencies bet...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 92ade217-4069-55a4-8bc1-82df4babd7b7
DOI: 10.21203/rs.3.rs-3978885/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myelomaDOI 10.21203/rs.3.rs-3978885/v1Read

The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma.Semantic proximity Read

Circulating plasma cells (either polyclonal or monoclonal) as markers of aggressive Multiple Myeloma phenotypeSemantic proximity Read

Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma.Semantic proximity Read

Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profileSemantic proximity Read

MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma PathologySemantic proximity Read

High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosisSemantic proximity Read

Clinical significance and molecular characteristics of circulating plasma cells in multiple myelomaSemantic proximity Read

High-risk disease in newly diagnosed multiple myeloma: beyond the R-ISS and IMWG definitionsSemantic proximity Read

Deep Phenotyping Reveals Distinct Immune Signatures Correlating with Prognostication, Treatment Responses, and MRD Status in Multiple MyelomaSemantic proximity Read

Genetic interrogation of circulating multiple myeloma cells at single-cell resolution.Semantic proximity Read

Revised International Staging System (R-ISS) stage-dependent analysis uncovers oncogenes and potential immunotherapeutic targets in multiple myeloma (MM)Semantic proximity Read

Mutational Profile and Prognostic Relevance of Circulating Tumor Cells in Multiple MyelomaSemantic proximity Read